0001104659-23-102863.txt : 20230921 0001104659-23-102863.hdr.sgml : 20230921 20230921171211 ACCESSION NUMBER: 0001104659-23-102863 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230912 FILED AS OF DATE: 20230921 DATE AS OF CHANGE: 20230921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paradigm Biocapital Advisors LP CENTRAL INDEX KEY: 0001855655 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39712 FILM NUMBER: 231269750 BUSINESS ADDRESS: STREET 1: 767 THIRD AVENUE, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 BUSINESS PHONE: 646-970-2123 MAIL ADDRESS: STREET 1: 767 THIRD AVENUE, 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paradigm BioCapital International Fund Ltd. CENTRAL INDEX KEY: 0001854392 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39712 FILM NUMBER: 231269748 BUSINESS ADDRESS: STREET 1: C/O WALKERS CORPORATE LIMITED STREET 2: 190 ELGIN AVENUE CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-9008 BUSINESS PHONE: (646) 970-2568 MAIL ADDRESS: STREET 1: C/O WALKERS CORPORATE LIMITED STREET 2: 190 ELGIN AVENUE CITY: GEORGE TOWN, GRAND CAYMAN STATE: E9 ZIP: KY1-9008 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Asefaw Senai CENTRAL INDEX KEY: 0001994183 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39712 FILM NUMBER: 231269747 MAIL ADDRESS: STREET 1: 767 THIRD AVENUE STREET 2: 17TH FLOOR CITY: NEW YORK CITY STATE: NY ZIP: 10017 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Paradigm BioCapital Advisors GP LLC CENTRAL INDEX KEY: 0001994082 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39712 FILM NUMBER: 231269749 BUSINESS ADDRESS: STREET 1: 767 THIRD AVENUE STREET 2: 17TH FLOOR CITY: NEW YORK CITY STATE: NY ZIP: 10017 BUSINESS PHONE: 646-970-2542 MAIL ADDRESS: STREET 1: 767 THIRD AVENUE STREET 2: 17TH FLOOR CITY: NEW YORK CITY STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Olema Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001750284 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 300409740 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 BUSINESS PHONE: (415) 651-3316 MAIL ADDRESS: STREET 1: 780 BRANNAN STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94103 3 1 tm2326131-2_3seq1.xml OWNERSHIP DOCUMENT X0206 3 2023-09-12 0 0001750284 Olema Pharmaceuticals, Inc. OLMA 0001855655 Paradigm Biocapital Advisors LP 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017 0 0 1 0 0001994082 Paradigm BioCapital Advisors GP LLC 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017 0 0 1 0 0001854392 Paradigm BioCapital International Fund Ltd. 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017 0 0 1 0 0001994183 Asefaw Senai 767 THIRD AVENUE, 17TH FLOOR NEW YORK NY 10017 0 0 1 0 Common Stock, par value $0.0001 per share 6490981 I By: Paradigm BioCapital International Fund Ltd. Common Stock, par value $0.0001 per share 1312619 I By: One or more separately managed accounts These securities are held directly by Paradigm BioCapital International Fund Ltd (the "Fund"). The Fund is a private investment vehicle. Paradigm BioCapital Advisors LP (the "Adviser") is the investment adviser of the Fund. Paradigm BioCapital Advisors GP LLC (the "Adviser GP") is the general partner of the Adviser. Senai Asefaw, M.D. is the managing member of the Adviser GP. Each Reporting Person disclaims beneficial ownership of all securities reported herein, except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose. These securities are held directly by one or more separately managed accounts managed by the Adviser. Each Reporting Person disclaims beneficial ownership of all securities reported herein, except to the extent of their pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities and Exchange Act of 1934 or for any other purpose. /s/ David Kim, as an authorized signatory of the Fund and the Adviser GP (for itself and on behalf of the Adviser) 2023-09-21 /s/ Senai Asefaw, M.D. 2023-09-21